Logo
  • About
    • What We Do
    • Team
    • Partners
  • Pipeline
  • Technologies
    • FastPharming®
    • Glycaneering℠
    • LicKM
    • VLP
  • Products
  • Resources
    • News
    • Events
    • Media
    • Scientific Content
  • Careers
  • Investors
  • Contact
  • Therapeutics
    • Oncology
      • IBIO-101
    • Fibrosis
      • IBIO-100
  • Vaccines
    • Covid-19
      • IBIO-202
    • Classic Swine Fever
      • IBIO-400
  • Research & Bioprocess
  • CDMO Services
    • Process Development
    • cGMP Manufacturing
    • Bioanalytics
    • mAb Solutions
    • Aseptic Fill/Finish
    • Factory Solutions
Investors

Press Releases

Investors

Investors

  • Overview
  • Company Info
    • Profile
    • Management Team
    • Presentations
  • News & Events
    • Press Releases
    • IR Calendar
  • Stock Data
    • Quote
    • Historical Data
  • SEC Filings
  • Corporate Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Resources
    • IR Contact
    • Email Alerts
    • Investor FAQ
  • News & Events

  • Press Releases
  • IR Calendar
Feb 03, 2020 4:15pm EST

iBio and CC-Pharming Initiate Joint Development of Coronavirus Vaccine

Jan 16, 2020 8:00am EST

iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance

Jan 06, 2020 9:15am EST

iBio Initiates New Litigation Against Fraunhofer

Dec 23, 2019 8:30am EST

iBio Announces Collaboration with EdgePoint AI for Next Gen Quality in Biologics Manufacturing

Dec 16, 2019 4:15pm EST

iBio Reports Progress on its Bio-Better Rituximab Collaboration with CC-Pharming

Dec 13, 2019 5:00pm EST

iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan

Dec 10, 2019 4:44pm EST

iBio Introduces FastGlycaneering Development Service™ to Power Recombinant Protein Production

Dec 03, 2019 12:31pm EST

iBio Joins Manufacturing USA’s Tissue Biofabrication Initiative

Dec 02, 2019 4:15pm EST

iBio to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference

Oct 25, 2019 8:30am EDT

iBio, Inc. Prices $5,000,000 Public Offering

  • Previous
  • 1…
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …15
  • Next
RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Footer Logo
  • Therapeutics
    • Oncology
      • IBIO-101
    • Fibrosis
      • IBIO-100
  • Vaccines
    • Covid-19
      • IBIO-202
    • Classic Swine Fever
      • IBIO-400
  • Research & Bioprocess
  • CDMO Services
    • Process Development
    • cGMP Manufacturing
    • Aseptic Fill/Finish
    • Bioanalytics
    • mAb Solutions
    • Factory Solutions

iBio, Inc.
iBio CDMO, LLC

8800 HSC Pkwy
Bryan, TX 77807

(979) 446-0027
LinkedIn
info@ibioinc.com
RSS News Feed

© 2022 iBio. All Rights Reserved.
Privacy Policy
Terms and Conditions

  • About
  • Pipeline
  • Technologies
  • Products
  • Resources
  • Careers
  • Investors
  • Contact